technetium tc 99m dimercaptosuccinic acid has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morrison, SC; O'Donnell, JK | 1 |
| Kivisaari, A; Lehtonen, T; Lindell, O | 1 |
2 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Bladder Cancer
| Article | Year |
|---|---|
Ifosfamide-induced alteration of technetium-99m-DMSA renal parenchymal imaging.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Tubules; Pyelonephritis; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma, Embryonal; Technetium Tc 99m Dimercaptosuccinic Acid; Urinary Bladder Neoplasms | 1997 |
99mTc-DTPA and 99mTc-DMSA renal gamma imaging in the surveillance of patients with conduit urinary diversion.
Topics: Adult; Aged; Creatinine; Female; Follow-Up Studies; Humans; Ileum; Kidney; Male; Middle Aged; Pentetic Acid; Radioisotope Renography; Risk; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Pentetate; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urinary Diversion | 1986 |